Robert L. Nussbaum - Nov 11, 2021 Form 4 Insider Report for Invitae Corp (NVTA)

Role
Chief Medical Officer
Signature
/s/ Thomas R. Brida, Attorney-in-Fact
Stock symbol
NVTA
Transactions as of
Nov 11, 2021
Transactions value $
-$350,371
Form type
4
Date filed
11/15/2021, 04:07 PM
Previous filing
Aug 18, 2021
Next filing
Mar 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVTA Common Stock Options Exercise $131K +13.3K +5.39% $9.90* 259K Nov 11, 2021 Direct
transaction NVTA Common Stock Options Exercise $168K +16.4K +6.33% $10.23* 276K Nov 11, 2021 Direct
transaction NVTA Common Stock Sale -$650K -29.7K -10.76% $21.89* 246K Nov 11, 2021 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVTA Employee Stock Options (right to buy) Options Exercise $0 -13.3K -24.87% $0.00 40.1K Nov 11, 2021 Common Stock 13.3K $9.90 Direct F4
transaction NVTA Employee Stock Options (right to buy) Options Exercise $0 -16.4K -23.44% $0.00 53.6K Nov 11, 2021 Common Stock 16.4K $10.23 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2021.
F2 Represents a weighted average sale price. Actual sale prices ranged from $21.62 to $22.30 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
F3 Includes an aggregate of 84,134 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
F4 The shares subject to this option are fully vested and exercisable.
F5 The shares subject to this option are fully vested and exercisable.